Target Product Profile (TPP) Analysis
Shape a Market-Ready and Differentiated Target Product Profile with Thelansis
A strong Target Product Profile is the foundation of successful development and commercialization. Our consultants help biopharma teams shape TPPs that are clinically meaningful, commercially viable, and competitively positioned from day one.
Our TPP analysis benchmarks your asset against clinical, regulatory, and commercial standards, plus unmet needs and competitive profiles to ensure it meets real-world requirements.
What We Do:
Using our evidence-driven frameworks and competitive data intelligence, we evaluate your asset against existing and emerging therapies to uncover the attributes that matter most for differentiation and uptake.
We review and refine key TPP components such as clinical endpoints, safety thresholds, delivery format, dosing, target population, and value messages.
Our team models multiple TPP scenarios to highlight: Achievable vs. Stretch clinical targets, Differentiation drivers vs. Current/Pipeline competitors, Payer requirements for premium access, Evidence expectations across major regulatory agencies, and Feasibility of proposed label claims.
A mid-stage biopharma company was advancing a novel CNS therapy into late Phase II, with early clinical signals suggesting meaningful benefit for patients with progressive neurological decline. While the science was promising, leadership faced a familiar CNS challenge: patients needed treatment sooner than regulatory and reimbursement timelines would allow.
Learn more: Designing an Early Access Pathway for a CNS Therapy Using Real-World and Claims Insights
A biopharma company was preparing to launch a first-in-class therapy in immunology TA. The asset showed strong clinical promise, but its commercial team faced a familiar challenge: every market had different payer expectations, and a single misstep on price in one country could trigger ripple effects across the global reference pricing network.
We Provide Answers to Critical Questions:
Each recommendation is grounded in scientific evidence, competitive intelligence, and realistic market expectations ensuring your TPP sets a solid direction for development.
What clinical performance thresholds are essential to compete?
Which product attributes will drive prescriber and payer preference?
What evidence is required to support the intended claims?
How will competitor evolution reshape expectations by launch year?
Need customize support?
Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.